View Profile

Ramon Eritja

Research Professor, Surfactants and Nanobiotechnology/ IQAC-CSIC · Spanish National Research Council (CSIC)

https://researchid.co/ramoneritja
@csic.es
441Scopus Publications
18252Google Scholar Citations
68Google Scholar h-index
324Google Scholar i10-index

Research Interests

Nucleic Acids Chemistry

Biography

Postdoctoral Fellow in Dr. Itakura’s (Beckman Research Institute at City of Hope, CA, USA, 1984-1988) and Dr. Caruthers’s (University of Colorado at Boulder, USA, 1988-1989) laboratories. Postdoctoral fellow, University of Barcelona, 1989-1990. Group Leader at CSIC, Barcelona, 1990-1994. Group Leader and responsible of DNA synthesis facility at EMBL, Heidelberg, Germany, 1994-1999. Research Professor at IBMB-CSIC leading the Nucleic Acid Chemistry Group since 1999. Invited member of the IRB Barcelona (2006-2012). Selected as member of the Networking Center on Bioengennering, Biomaterials and Nanomedicine of Spain (CIBER-BBN) since 2006. Director of institute (IQAC, 2012-2017). Expertise on oligonucleotide and peptide synthesis especially on the methodological aspects of solid-phase synthesis (monomer synthesis, preparation of solid supports, synthesis and purification). Experience in most areas related to the synthesis and properties of oligonucleotide derivatives.

Education

B. Sc. Chemistry, University of Barcelona, 1977. B. Sc. Pharmacy, University of Barcelona 1982. Ph.D. Chemistry, University of Barcelona, 1983.

Recent Scopus Publications

  1. Covalent functionalization of polymeric nanoparticles prepared from nano-emulsion templates for gene silencing and antioxidant delivery at neuronal level
    International Journal of Pharmaceutics, 2026
  2. Enhanced muscle uptake of chemically optimized miR-23b antisense oligonucleotides as lead compounds for myotonic dystrophy type 1
    American Journal of Human Genetics, 2026
  3. Conjugation strategy shapes antitumor efficacy and enables dose-sparing in non-antibody protein nanoconjugates
    Materials Today Bio, 2026
  4. G-quadruplexes as therapeutic platforms for anticancer drug delivery: from intrinsic cytotoxicity to drug delivery and nanotechnology
    Expert Opinion on Drug Delivery, 2026
  5. Engineering G-quadruplex aptamer-5-fluoro-2′-deoxyuridine conjugates: Impact of tail orientation and RNA spacer insertion on structure and antitumor activity
    International Journal of Biological Macromolecules, 2026

Links